Japanese Guideline for childhood Asthma

Allergology International

Volumn 60, Issue 2, 2011, Pages 147-169

  Nishimuta, Toshiyuki ^a   Kondo, Naomi ^b   Hamasaki, Yuhei ^c   Morikawa, Akihiro ^d   Nishima, Sankei ^e  

^a SHIMOSHIZU HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d Kita Kanto Allergy Laboratory   (Japan)

^e FUKUOKA NATIONAL HOSPITAL   (Japan)

Author keywords

Acute attack; Childhood asthma; Guideline; Long term management; Prevention

Indexed keywords

ADOAIR; AMINOPHYLLINE; ANTIINFLAMMATORY AGENT; ASTHPUL; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DEXAMETHASONE; E HALER; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; ISOPRENALINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MEASLES RUBELLA VACCINE; METHYLPREDNISOLONE; PREDNISOLONE; PROCATEROL; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SALMETEROL XINAFOATE; SHORT ACTING DRUG; STEROID; THEOPHYLLINE; TULOBUTEROL; UNCLASSIFIED DRUG;

ADOLESCENT DISEASE; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY TEST; ARTIFICIAL VENTILATION; ASTHMA; ATELECTASIS; ATOPIC DERMATITIS; BENIGN CHILDHOOD EPILEPSY; BREATHING DISORDER; CAUSE OF DEATH; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; COUGH VARIANT ASTHMA; CYANOSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ELIXIR; ENVIRONMENTAL FACTOR; EVENING DOSAGE; HUMAN; INFANT DISEASE; INFLUENZA; INFUSION RATE; INHALATION SPACER; INHALER; JAPANESE; LONG TERM CARE; MEASLES; MEDICAL NEBULIZER; METERED DOSE INHALER; OBSTRUCTIVE AIRWAY DISEASE; OUTPATIENT DEPARTMENT; OXYGENATION; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT REFERRAL; PEDIATRIC SURGERY; PNEUMOMEDIASTINUM; PNEUMONIA; PNEUMOTHORAX; POLLEN ALLERGY; PRACTICE GUIDELINE; PREVENTION STUDY; PRIORITY JOURNAL; PROGNOSIS; PUBERTY; RESPIRATORY FAILURE; RETREATMENT; REVIEW; RUBELLA; SCHOOL HEALTH SERVICE; SEIZURE; SMOKING CESSATION; SUBCUTANEOUS EMPHYSEMA; TACHYPNEA; TREATMENT INDICATION; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VACCINATION; WHEEZING;

EID: 79959621645     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-RAI-0328     Document Type: Review

References (54)

1. Krawiec ME, Westcott JY, Chu HW et al. Presistent wheezing in very young childdren is associated with lower respiratory inflammation. Am J Respir Crit Care Med 2001;163:1138-43.
2. Baraldi E, Dario C, Ongaro R et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 1999;159:1284-8.
3. Payne DN, Qiu Y, Zhn J et al. Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax 2004;59:862-9.
4. Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003;67:78-82.
5. Jenkins HA, Cool C, Szefler SJ et al. Histopathology of severe childhood Asthma: a case series. Chest 2003;124:32-41.
6. Barbato A, Turato G, Baraldo S et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003; 168:798-803.
7. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107-13.
8. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation bronchial asthma. N Engl J Med 1979;300:633-7.
9. Fujimura M, Kamito Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patient with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J Asthma 1994;31:463-72.
10. Niini A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11:1064-9.
11. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Recommended respiratory disease questionnaires for use with adult and children in epidemiological research. Am Rev Respir Dis 1978;118:7-53.
12. Study Group of the Prevalence of Allergic Diseases West Japan Study Group of Allergy in Children. [A study on the prevalence of allergic diseases in school children In western districts of Japan: Comparison between the studies in 1992 and 2002 with the same methods and same districts]. [Jpn J Pediatr Allergy Clin Immunol] 2003;17:255-68 (in Japanese).
13. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence on symptoms of asthma, allergic Rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225-32.
14. Nishima S, Odajima H. [Prevalence of Childhood allergic diseases in Japan using international study of asthma and allergies in childhood (ISAAC) phase I protocol]. [Jpn J Pediatr Allergy Clin Immunol] 2002;16:207-20 (in Japanese).
15. Committee on Asthma Death in Japanese Children, The Japanese Society of Pediatric Allergy and Clinical Immunology. [Asthma death in Japanese children. Committee report in 2006]. [Jpn J Pediatr Allergy Clin Immunol] 2007; 21:331-44 (in Japanese).
16. Committee on Asthma Death in Japanese Children, The Japanese Society of Pediatric Allergy and Clinical Immunology. [Asthma death in Japanese children. Committee report in 2002]. [Jpn J Pediatr Allergy ClinImmunol] 2003; 17:290-302 (in Japanese).
17. Iikura Y, Matsumoto T, Fujita K et al. Continuous isoproterenol inharation therapy in children with severe asthmatic attack. Int Arch Allergy Immunol 1997;113:370-2.
18. Takamasu T, Kurihara K, Goto K, Inomata N. [Isoproterenol continuous nebulization of childhood status asthmaticus. II. Efficacy and side effect of low-dose method comparing with high dose method]. [Jpn J Allergol] 1998;47: 573-81 (in Japanese).
19. Hanania NA, Moore RH, Zimmerman JL et al. The role of intrinsic efficacy in determining response to a betaagonist in acute severe asthma. Respir Med 2007;101: 1007-14.
20. Liu AH, Zeiger R, Sorkness C et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007;119:817-25.
21. Nishimuta T, Watanabe H, Sato K, Nezu S, Matsuura T, Suzuki S. [A study on the usefulness of the Japanese Pediatric asthma control program (JPAC)]. [Jpn J Pediatr Allergy Clin Immunol] 2008;22:135-45 (in Japanese).
22. Hanrahan JP, Tager IB, Segal MR et al. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992;145:1129-35.
23. Lemanske RF Jr, Sorkness CA, Mauger ER et al, and Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeteol: a recommended controlled trial. JAMA 2001;285:2594-603.
24. Calpin C, Macarthur C, Stephens D, Feldman W, Parkin PC. Effectiveness of prophylactic inhaled steroids in children asthma: a systemic review of the literature. J Allergy Clin Immunol 1997;100:452-7.
25. The Childhood Asthma Management Program Research Groop. Long term effects of Budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.
26. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Lowdose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
27. Stelmach I, Jerzynska J, Kuna P. A randomized, doubleblind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL4 and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 2002;109:257-63.
28. Bukstein DA, Luskin AT, Berntein A. Real-world effectiveness of daily controller medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol 2003;90: 543-9.
29. Garcia MLG, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast, compared with fulticazone, for control of asthma among 6-to 14year-old patient with mild asthma: The MOSAIC study. Pediatr 2005;116:360-9.
30. Williams B, Noonan G, Reiss TF. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin Exp Allergy 2000;31:845-54.
31. Simons FER, Villa JR, Lee BW et al. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr 2001;138: 694-8.
32. Phipatanakul W, Greene C, Downes SJ et al. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Ann Allergy Asthma Immunol 2003;91:49-54.
33. Odajima Y, Nakano H, Kato T. [Clinical review on patients who developed seizures during theophylline administration: relationships with seizure-predisposing factors]. [Jpn J Allergol] 2006;55:1295-303 (in Japanese).
34. Nishima S, Furusho K, Mukoyama T et al. [Effect of tulobuterol Patch on airway hypersensitivity in children with bronchial asthma, A multicenter double-blind double-durmmy comparative study]. [Jpn J Pediatr Allergy Clin Immunol] 2003;17:204-9 (in Japanese).
35. Yosihara S, Yamada Y, Abe T, Arisaka O. The use of a patch formulation of tulobuterol, a long-acting p2-adrenoreceptor agonist, in the treatment of severe pediatric asthma. Ann Allergy Asthma Immunol 2006;96:879-80.
36. Sly PD. Peak flow monitoring in children. Monaldi Arch Chest Dis 1993;48:662-7.
37. Kano S, Kiba M, Koga K, Nishio K, Odajima H, Nishima S. [Usefulness of long term PEF monitoring in asthmatic children]. [Jpn J Pediatr Allergy Clin Immunol] 1998;12: 41-9 (in Japanese).
38. Nishimuta T. Special therapy in an institutional hospital. Acta Pediatr Jpn 1990;32:201-4.
39. Bisgaard H. Patient related factors in nebulized drug delivery to children. Eur Respir Rev 1997;7:376-7.
40. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolized drug in infants. Arch Dis Child 1999;81:163-5.
41. Agertoft L, Pedersen S. Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994;71:217-9.
42. Janssens HM, Krijgsman A, Verbraak TF, Hop WC, de Jongste JC, Tiddens HA. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model. J Aerosol Med 2004;17:51-61.
43. Nishima S, Morikawa A. [Various problems associated with inhalation spacers]. [Jpn J Allergol] 2008;57:1-4 (in Japanese).
44. Strauss RH, McFadden ER Jr, Ingram RH Jr, Jaeger JJ. Enhancement of exercise-induced asthma by cold air. N Engl J Med 1977;297:743-7.
45. Anderson SD, Schoeffel RE, Follet R, Perry CP, Daviskas E, Kendall M. Sensitivity to heat and water loss at rest and during exercise in asthmatic patients. Eur J Respir Dis 1982;63:459-71.
46. Hahn A, Anderson SD, Morton AR, Black JL, Fitch KD. A Reinterpretation of the effect of temperature and water content of the inspired air in exercise-induced asthma. Am Rev Respir Dis 1984;130:575-9.
47. McFadden ER Jr, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. J Clin Invest 1986;78:18-25.
48. Nishima S, Akasaka T, Arai Y et al. Standardization of the severity of exercise-induced Bronchospasm in Japanese children with asthma. Acta Pediatr Jpn 1983;25:253-43.
49. Shinomiya K, Akasaka T, Arai Y et al. [Qualitative and Quantitative examination of exercise for assessing exercise-induced asthma in clinical practice. Part 1. Treadmill exercise test]. [Jpn J Allergol] 1981;30:235-43 (in Japanese).
50. Nishima S, Kaizuka H, Araki H, Koizumi S. [Comparison of the severity of asthmatic symptoms with that of exercise-induced bronchospasm (EIB) in asthmatic children. 1. An investigation using a bicycle ergometer]. [Jpn J Allergol] 1981;30:1113-22 (in Japanese).
51. Gibson PG, Ram FS, Powell H. Asthma education. Respir Med 2003;97:1036-44.
52. Guevara JP, Wolf F, Grum CM, Clark NM. Effects of educational interventions for self management of asthma in children and adolescents: systematic review and metaanalysis. BMJ 2003;326:1308-9.
53. Ley P. Improving patient's understanding, recall, satisfaction and compliance. In: Broome AK (ed). Health Psycology. London: Chapman & Hall, 1989.
54. Nishima S. Treatment and management of severe asthma in children through to young adult patients. Allergol Int 2001;50:249-64.